Global Liquid Biopsy Market Growth (Status and Outlook) 2026-2032
The global Liquid Biopsy market size is predicted to grow from US$ 4487 million in 2025 to US$ 16020 million in 2032; it is expected to grow at a CAGR of 19.9% from 2026 to 2032.
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
LPI (LP Information)' newest research report, the ?Liquid Biopsy Industry Forecast? looks at past sales and reviews total world Liquid Biopsy sales in 2025, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy sales for 2026 through 2032. With Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
LPI (LP Information)' newest research report, the ?Liquid Biopsy Industry Forecast? looks at past sales and reviews total world Liquid Biopsy sales in 2025, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy sales for 2026 through 2032. With Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Test Suite
- Equipment
- Service
- NGS Sequencing
- Digital PCR
- Real-time PCR
- Other
- Blood Sample
- Urine Sample
- Other
- Hospitals Labs
- Reference Labs
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- RainDanceTechnologies
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- Biocept
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Silicon Biosystems
- Adaptive Biotechnologies
- 4D Lifetec
- Roche
- Illumina
- Exact Sciences
- Natera
- Foundation Medicine
- Thermo Fisher Scientific
- Bio-Rad Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liquid Biopsy Market Size (2021-2032)
2.1.2 Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Liquid Biopsy by Country/Region (2021, 2025 & 2032)
2.2 Liquid Biopsy Segment by Type
2.2.1 Test Suite
2.2.2 Equipment
2.2.3 Service
2.2.4 Liquid Biopsy Market Size by Type
2.2.4.1 Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
2.3 Liquid Biopsy Segment by Technology Platform
2.3.1 NGS Sequencing
2.3.2 Digital PCR
2.3.3 Real-time PCR
2.3.4 Other
2.3.5 Liquid Biopsy Market Size by Technology Platform
2.3.5.1 Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032)
2.3.5.2 Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
2.4 Liquid Biopsy Segment by Sample
2.4.1 Blood Sample
2.4.2 Urine Sample
2.4.3 Other
2.4.4 Liquid Biopsy Market Size by Sample
2.4.4.1 Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032)
2.4.4.2 Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
2.5 Liquid Biopsy Segment by Application
2.5.1 Hospitals Labs
2.5.2 Reference Labs
2.5.3 Other
2.5.4 Liquid Biopsy Market Size by Application
2.5.4.1 Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Liquid Biopsy Market Size Market Share by Application (2021-2026)
3 LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Liquid Biopsy Market Size Market Share by Player
3.1.1 Global Liquid Biopsy Revenue by Player (2021-2026)
3.1.2 Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
3.2 Global Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIQUID BIOPSY BY REGION
4.1 Liquid Biopsy Market Size by Region (2021-2026)
4.2 Global Liquid Biopsy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Liquid Biopsy Market Size Growth (2021-2026)
4.4 APAC Liquid Biopsy Market Size Growth (2021-2026)
4.5 Europe Liquid Biopsy Market Size Growth (2021-2026)
4.6 Middle East & Africa Liquid Biopsy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Liquid Biopsy Market Size by Country (2021-2026)
5.2 Americas Liquid Biopsy Market Size by Type (2021-2026)
5.3 Americas Liquid Biopsy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy Market Size by Region (2021-2026)
6.2 APAC Liquid Biopsy Market Size by Type (2021-2026)
6.3 APAC Liquid Biopsy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Liquid Biopsy Market Size by Country (2021-2026)
7.2 Europe Liquid Biopsy Market Size by Type (2021-2026)
7.3 Europe Liquid Biopsy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liquid Biopsy by Region (2021-2026)
8.2 Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026)
8.3 Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIQUID BIOPSY MARKET FORECAST
10.1 Global Liquid Biopsy Forecast by Region (2027-2032)
10.1.1 Global Liquid Biopsy Forecast by Region (2027-2032)
10.1.2 Americas Liquid Biopsy Forecast
10.1.3 APAC Liquid Biopsy Forecast
10.1.4 Europe Liquid Biopsy Forecast
10.1.5 Middle East & Africa Liquid Biopsy Forecast
10.2 Americas Liquid Biopsy Forecast by Country (2027-2032)
10.2.1 United States Market Liquid Biopsy Forecast
10.2.2 Canada Market Liquid Biopsy Forecast
10.2.3 Mexico Market Liquid Biopsy Forecast
10.2.4 Brazil Market Liquid Biopsy Forecast
10.3 APAC Liquid Biopsy Forecast by Region (2027-2032)
10.3.1 China Liquid Biopsy Market Forecast
10.3.2 Japan Market Liquid Biopsy Forecast
10.3.3 Korea Market Liquid Biopsy Forecast
10.3.4 Southeast Asia Market Liquid Biopsy Forecast
10.3.5 India Market Liquid Biopsy Forecast
10.3.6 Australia Market Liquid Biopsy Forecast
10.4 Europe Liquid Biopsy Forecast by Country (2027-2032)
10.4.1 Germany Market Liquid Biopsy Forecast
10.4.2 France Market Liquid Biopsy Forecast
10.4.3 UK Market Liquid Biopsy Forecast
10.4.4 Italy Market Liquid Biopsy Forecast
10.4.5 Russia Market Liquid Biopsy Forecast
10.5 Middle East & Africa Liquid Biopsy Forecast by Region (2027-2032)
10.5.1 Egypt Market Liquid Biopsy Forecast
10.5.2 South Africa Market Liquid Biopsy Forecast
10.5.3 Israel Market Liquid Biopsy Forecast
10.5.4 Turkey Market Liquid Biopsy Forecast
10.6 Global Liquid Biopsy Forecast by Type (2027-2032)
10.7 Global Liquid Biopsy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Liquid Biopsy Forecast
11 KEY PLAYERS ANALYSIS
11.1 RainDanceTechnologies
11.1.1 RainDanceTechnologies Company Information
11.1.2 RainDanceTechnologies Liquid Biopsy Product Offered
11.1.3 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 RainDanceTechnologies Main Business Overview
11.1.5 RainDanceTechnologies Latest Developments
11.2 Biocartis
11.2.1 Biocartis Company Information
11.2.2 Biocartis Liquid Biopsy Product Offered
11.2.3 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Biocartis Main Business Overview
11.2.5 Biocartis Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Liquid Biopsy Product Offered
11.3.3 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Guardant Health
11.4.1 Guardant Health Company Information
11.4.2 Guardant Health Liquid Biopsy Product Offered
11.4.3 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Guardant Health Main Business Overview
11.4.5 Guardant Health Latest Developments
11.5 MDxHealth
11.5.1 MDxHealth Company Information
11.5.2 MDxHealth Liquid Biopsy Product Offered
11.5.3 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MDxHealth Main Business Overview
11.5.5 MDxHealth Latest Developments
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Information
11.6.2 Pathway Genomics Liquid Biopsy Product Offered
11.6.3 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pathway Genomics Main Business Overview
11.6.5 Pathway Genomics Latest Developments
11.7 Biocept
11.7.1 Biocept Company Information
11.7.2 Biocept Liquid Biopsy Product Offered
11.7.3 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Biocept Main Business Overview
11.7.5 Biocept Latest Developments
11.8 NeoGenomics Laboraories
11.8.1 NeoGenomics Laboraories Company Information
11.8.2 NeoGenomics Laboraories Liquid Biopsy Product Offered
11.8.3 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NeoGenomics Laboraories Main Business Overview
11.8.5 NeoGenomics Laboraories Latest Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Information
11.9.2 Sysmex Inostics Liquid Biopsy Product Offered
11.9.3 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sysmex Inostics Main Business Overview
11.9.5 Sysmex Inostics Latest Developments
11.10 Cynvenio
11.10.1 Cynvenio Company Information
11.10.2 Cynvenio Liquid Biopsy Product Offered
11.10.3 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cynvenio Main Business Overview
11.10.5 Cynvenio Latest Developments
11.11 Silicon Biosystems
11.11.1 Silicon Biosystems Company Information
11.11.2 Silicon Biosystems Liquid Biopsy Product Offered
11.11.3 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Silicon Biosystems Main Business Overview
11.11.5 Silicon Biosystems Latest Developments
11.12 Adaptive Biotechnologies
11.12.1 Adaptive Biotechnologies Company Information
11.12.2 Adaptive Biotechnologies Liquid Biopsy Product Offered
11.12.3 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Adaptive Biotechnologies Main Business Overview
11.12.5 Adaptive Biotechnologies Latest Developments
11.13 4D Lifetec
11.13.1 4D Lifetec Company Information
11.13.2 4D Lifetec Liquid Biopsy Product Offered
11.13.3 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 4D Lifetec Main Business Overview
11.13.5 4D Lifetec Latest Developments
11.14 Roche
11.14.1 Roche Company Information
11.14.2 Roche Liquid Biopsy Product Offered
11.14.3 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Roche Main Business Overview
11.14.5 Roche Latest Developments
11.15 Illumina
11.15.1 Illumina Company Information
11.15.2 Illumina Liquid Biopsy Product Offered
11.15.3 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Illumina Main Business Overview
11.15.5 Illumina Latest Developments
11.16 Exact Sciences
11.16.1 Exact Sciences Company Information
11.16.2 Exact Sciences Liquid Biopsy Product Offered
11.16.3 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Exact Sciences Main Business Overview
11.16.5 Exact Sciences Latest Developments
11.17 Natera
11.17.1 Natera Company Information
11.17.2 Natera Liquid Biopsy Product Offered
11.17.3 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Natera Main Business Overview
11.17.5 Natera Latest Developments
11.18 Foundation Medicine
11.18.1 Foundation Medicine Company Information
11.18.2 Foundation Medicine Liquid Biopsy Product Offered
11.18.3 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Foundation Medicine Main Business Overview
11.18.5 Foundation Medicine Latest Developments
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Information
11.19.2 Thermo Fisher Scientific Liquid Biopsy Product Offered
11.19.3 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Thermo Fisher Scientific Main Business Overview
11.19.5 Thermo Fisher Scientific Latest Developments
11.20 Bio-Rad Laboratories
11.20.1 Bio-Rad Laboratories Company Information
11.20.2 Bio-Rad Laboratories Liquid Biopsy Product Offered
11.20.3 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Bio-Rad Laboratories Main Business Overview
11.20.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liquid Biopsy Market Size (2021-2032)
2.1.2 Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Liquid Biopsy by Country/Region (2021, 2025 & 2032)
2.2 Liquid Biopsy Segment by Type
2.2.1 Test Suite
2.2.2 Equipment
2.2.3 Service
2.2.4 Liquid Biopsy Market Size by Type
2.2.4.1 Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
2.3 Liquid Biopsy Segment by Technology Platform
2.3.1 NGS Sequencing
2.3.2 Digital PCR
2.3.3 Real-time PCR
2.3.4 Other
2.3.5 Liquid Biopsy Market Size by Technology Platform
2.3.5.1 Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032)
2.3.5.2 Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
2.4 Liquid Biopsy Segment by Sample
2.4.1 Blood Sample
2.4.2 Urine Sample
2.4.3 Other
2.4.4 Liquid Biopsy Market Size by Sample
2.4.4.1 Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032)
2.4.4.2 Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
2.5 Liquid Biopsy Segment by Application
2.5.1 Hospitals Labs
2.5.2 Reference Labs
2.5.3 Other
2.5.4 Liquid Biopsy Market Size by Application
2.5.4.1 Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Liquid Biopsy Market Size Market Share by Application (2021-2026)
3 LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Liquid Biopsy Market Size Market Share by Player
3.1.1 Global Liquid Biopsy Revenue by Player (2021-2026)
3.1.2 Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
3.2 Global Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIQUID BIOPSY BY REGION
4.1 Liquid Biopsy Market Size by Region (2021-2026)
4.2 Global Liquid Biopsy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Liquid Biopsy Market Size Growth (2021-2026)
4.4 APAC Liquid Biopsy Market Size Growth (2021-2026)
4.5 Europe Liquid Biopsy Market Size Growth (2021-2026)
4.6 Middle East & Africa Liquid Biopsy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Liquid Biopsy Market Size by Country (2021-2026)
5.2 Americas Liquid Biopsy Market Size by Type (2021-2026)
5.3 Americas Liquid Biopsy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy Market Size by Region (2021-2026)
6.2 APAC Liquid Biopsy Market Size by Type (2021-2026)
6.3 APAC Liquid Biopsy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Liquid Biopsy Market Size by Country (2021-2026)
7.2 Europe Liquid Biopsy Market Size by Type (2021-2026)
7.3 Europe Liquid Biopsy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liquid Biopsy by Region (2021-2026)
8.2 Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026)
8.3 Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIQUID BIOPSY MARKET FORECAST
10.1 Global Liquid Biopsy Forecast by Region (2027-2032)
10.1.1 Global Liquid Biopsy Forecast by Region (2027-2032)
10.1.2 Americas Liquid Biopsy Forecast
10.1.3 APAC Liquid Biopsy Forecast
10.1.4 Europe Liquid Biopsy Forecast
10.1.5 Middle East & Africa Liquid Biopsy Forecast
10.2 Americas Liquid Biopsy Forecast by Country (2027-2032)
10.2.1 United States Market Liquid Biopsy Forecast
10.2.2 Canada Market Liquid Biopsy Forecast
10.2.3 Mexico Market Liquid Biopsy Forecast
10.2.4 Brazil Market Liquid Biopsy Forecast
10.3 APAC Liquid Biopsy Forecast by Region (2027-2032)
10.3.1 China Liquid Biopsy Market Forecast
10.3.2 Japan Market Liquid Biopsy Forecast
10.3.3 Korea Market Liquid Biopsy Forecast
10.3.4 Southeast Asia Market Liquid Biopsy Forecast
10.3.5 India Market Liquid Biopsy Forecast
10.3.6 Australia Market Liquid Biopsy Forecast
10.4 Europe Liquid Biopsy Forecast by Country (2027-2032)
10.4.1 Germany Market Liquid Biopsy Forecast
10.4.2 France Market Liquid Biopsy Forecast
10.4.3 UK Market Liquid Biopsy Forecast
10.4.4 Italy Market Liquid Biopsy Forecast
10.4.5 Russia Market Liquid Biopsy Forecast
10.5 Middle East & Africa Liquid Biopsy Forecast by Region (2027-2032)
10.5.1 Egypt Market Liquid Biopsy Forecast
10.5.2 South Africa Market Liquid Biopsy Forecast
10.5.3 Israel Market Liquid Biopsy Forecast
10.5.4 Turkey Market Liquid Biopsy Forecast
10.6 Global Liquid Biopsy Forecast by Type (2027-2032)
10.7 Global Liquid Biopsy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Liquid Biopsy Forecast
11 KEY PLAYERS ANALYSIS
11.1 RainDanceTechnologies
11.1.1 RainDanceTechnologies Company Information
11.1.2 RainDanceTechnologies Liquid Biopsy Product Offered
11.1.3 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 RainDanceTechnologies Main Business Overview
11.1.5 RainDanceTechnologies Latest Developments
11.2 Biocartis
11.2.1 Biocartis Company Information
11.2.2 Biocartis Liquid Biopsy Product Offered
11.2.3 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Biocartis Main Business Overview
11.2.5 Biocartis Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Liquid Biopsy Product Offered
11.3.3 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Guardant Health
11.4.1 Guardant Health Company Information
11.4.2 Guardant Health Liquid Biopsy Product Offered
11.4.3 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Guardant Health Main Business Overview
11.4.5 Guardant Health Latest Developments
11.5 MDxHealth
11.5.1 MDxHealth Company Information
11.5.2 MDxHealth Liquid Biopsy Product Offered
11.5.3 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MDxHealth Main Business Overview
11.5.5 MDxHealth Latest Developments
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Information
11.6.2 Pathway Genomics Liquid Biopsy Product Offered
11.6.3 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pathway Genomics Main Business Overview
11.6.5 Pathway Genomics Latest Developments
11.7 Biocept
11.7.1 Biocept Company Information
11.7.2 Biocept Liquid Biopsy Product Offered
11.7.3 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Biocept Main Business Overview
11.7.5 Biocept Latest Developments
11.8 NeoGenomics Laboraories
11.8.1 NeoGenomics Laboraories Company Information
11.8.2 NeoGenomics Laboraories Liquid Biopsy Product Offered
11.8.3 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NeoGenomics Laboraories Main Business Overview
11.8.5 NeoGenomics Laboraories Latest Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Information
11.9.2 Sysmex Inostics Liquid Biopsy Product Offered
11.9.3 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sysmex Inostics Main Business Overview
11.9.5 Sysmex Inostics Latest Developments
11.10 Cynvenio
11.10.1 Cynvenio Company Information
11.10.2 Cynvenio Liquid Biopsy Product Offered
11.10.3 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cynvenio Main Business Overview
11.10.5 Cynvenio Latest Developments
11.11 Silicon Biosystems
11.11.1 Silicon Biosystems Company Information
11.11.2 Silicon Biosystems Liquid Biopsy Product Offered
11.11.3 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Silicon Biosystems Main Business Overview
11.11.5 Silicon Biosystems Latest Developments
11.12 Adaptive Biotechnologies
11.12.1 Adaptive Biotechnologies Company Information
11.12.2 Adaptive Biotechnologies Liquid Biopsy Product Offered
11.12.3 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Adaptive Biotechnologies Main Business Overview
11.12.5 Adaptive Biotechnologies Latest Developments
11.13 4D Lifetec
11.13.1 4D Lifetec Company Information
11.13.2 4D Lifetec Liquid Biopsy Product Offered
11.13.3 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 4D Lifetec Main Business Overview
11.13.5 4D Lifetec Latest Developments
11.14 Roche
11.14.1 Roche Company Information
11.14.2 Roche Liquid Biopsy Product Offered
11.14.3 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Roche Main Business Overview
11.14.5 Roche Latest Developments
11.15 Illumina
11.15.1 Illumina Company Information
11.15.2 Illumina Liquid Biopsy Product Offered
11.15.3 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Illumina Main Business Overview
11.15.5 Illumina Latest Developments
11.16 Exact Sciences
11.16.1 Exact Sciences Company Information
11.16.2 Exact Sciences Liquid Biopsy Product Offered
11.16.3 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Exact Sciences Main Business Overview
11.16.5 Exact Sciences Latest Developments
11.17 Natera
11.17.1 Natera Company Information
11.17.2 Natera Liquid Biopsy Product Offered
11.17.3 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Natera Main Business Overview
11.17.5 Natera Latest Developments
11.18 Foundation Medicine
11.18.1 Foundation Medicine Company Information
11.18.2 Foundation Medicine Liquid Biopsy Product Offered
11.18.3 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Foundation Medicine Main Business Overview
11.18.5 Foundation Medicine Latest Developments
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Information
11.19.2 Thermo Fisher Scientific Liquid Biopsy Product Offered
11.19.3 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Thermo Fisher Scientific Main Business Overview
11.19.5 Thermo Fisher Scientific Latest Developments
11.20 Bio-Rad Laboratories
11.20.1 Bio-Rad Laboratories Company Information
11.20.2 Bio-Rad Laboratories Liquid Biopsy Product Offered
11.20.3 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Bio-Rad Laboratories Main Business Overview
11.20.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Liquid Biopsy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Test Suite
Table 4. Major Players of Equipment
Table 5. Major Players of Service
Table 6. Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of NGS Sequencing
Table 10. Major Players of Digital PCR
Table 11. Major Players of Real-time PCR
Table 12. Major Players of Other
Table 13. Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Liquid Biopsy Market Size by Technology Platform (2021-2026) & ($ millions)
Table 15. Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
Table 16. Major Players of Blood Sample
Table 17. Major Players of Urine Sample
Table 18. Major Players of Other
Table 19. Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Liquid Biopsy Market Size by Sample (2021-2026) & ($ millions)
Table 21. Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
Table 22. Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 25. Global Liquid Biopsy Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
Table 27. Liquid Biopsy Key Players Head office and Products Offered
Table 28. Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 33. Global Liquid Biopsy Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Liquid Biopsy Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 37. Americas Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 39. Americas Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 41. APAC Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 43. APAC Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 47. Europe Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Liquid Biopsy
Table 53. Key Market Challenges & Risks of Liquid Biopsy
Table 54. Key Industry Trends of Liquid Biopsy
Table 55. Global Liquid Biopsy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Liquid Biopsy Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Liquid Biopsy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Liquid Biopsy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. RainDanceTechnologies Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 60. RainDanceTechnologies Liquid Biopsy Product Offered
Table 61. RainDanceTechnologies Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. RainDanceTechnologies Main Business
Table 63. RainDanceTechnologies Latest Developments
Table 64. Biocartis Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 65. Biocartis Liquid Biopsy Product Offered
Table 66. Biocartis Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Biocartis Main Business
Table 68. Biocartis Latest Developments
Table 69. Qiagen Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 70. Qiagen Liquid Biopsy Product Offered
Table 71. Qiagen Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Qiagen Main Business
Table 73. Qiagen Latest Developments
Table 74. Guardant Health Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 75. Guardant Health Liquid Biopsy Product Offered
Table 76. Guardant Health Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Guardant Health Main Business
Table 78. Guardant Health Latest Developments
Table 79. MDxHealth Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 80. MDxHealth Liquid Biopsy Product Offered
Table 81. MDxHealth Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. MDxHealth Main Business
Table 83. MDxHealth Latest Developments
Table 84. Pathway Genomics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 85. Pathway Genomics Liquid Biopsy Product Offered
Table 86. Pathway Genomics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Pathway Genomics Main Business
Table 88. Pathway Genomics Latest Developments
Table 89. Biocept Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 90. Biocept Liquid Biopsy Product Offered
Table 91. Biocept Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Biocept Main Business
Table 93. Biocept Latest Developments
Table 94. NeoGenomics Laboraories Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 95. NeoGenomics Laboraories Liquid Biopsy Product Offered
Table 96. NeoGenomics Laboraories Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. NeoGenomics Laboraories Main Business
Table 98. NeoGenomics Laboraories Latest Developments
Table 99. Sysmex Inostics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 100. Sysmex Inostics Liquid Biopsy Product Offered
Table 101. Sysmex Inostics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Sysmex Inostics Main Business
Table 103. Sysmex Inostics Latest Developments
Table 104. Cynvenio Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 105. Cynvenio Liquid Biopsy Product Offered
Table 106. Cynvenio Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Cynvenio Main Business
Table 108. Cynvenio Latest Developments
Table 109. Silicon Biosystems Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 110. Silicon Biosystems Liquid Biopsy Product Offered
Table 111. Silicon Biosystems Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Silicon Biosystems Main Business
Table 113. Silicon Biosystems Latest Developments
Table 114. Adaptive Biotechnologies Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 115. Adaptive Biotechnologies Liquid Biopsy Product Offered
Table 116. Adaptive Biotechnologies Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Adaptive Biotechnologies Main Business
Table 118. Adaptive Biotechnologies Latest Developments
Table 119. 4D Lifetec Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 120. 4D Lifetec Liquid Biopsy Product Offered
Table 121. 4D Lifetec Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. 4D Lifetec Main Business
Table 123. 4D Lifetec Latest Developments
Table 124. Roche Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 125. Roche Liquid Biopsy Product Offered
Table 126. Roche Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Roche Main Business
Table 128. Roche Latest Developments
Table 129. Illumina Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 130. Illumina Liquid Biopsy Product Offered
Table 131. Illumina Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Illumina Main Business
Table 133. Illumina Latest Developments
Table 134. Exact Sciences Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 135. Exact Sciences Liquid Biopsy Product Offered
Table 136. Exact Sciences Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Exact Sciences Main Business
Table 138. Exact Sciences Latest Developments
Table 139. Natera Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 140. Natera Liquid Biopsy Product Offered
Table 141. Natera Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Natera Main Business
Table 143. Natera Latest Developments
Table 144. Foundation Medicine Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 145. Foundation Medicine Liquid Biopsy Product Offered
Table 146. Foundation Medicine Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Foundation Medicine Main Business
Table 148. Foundation Medicine Latest Developments
Table 149. Thermo Fisher Scientific Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 150. Thermo Fisher Scientific Liquid Biopsy Product Offered
Table 151. Thermo Fisher Scientific Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Thermo Fisher Scientific Main Business
Table 153. Thermo Fisher Scientific Latest Developments
Table 154. Bio-Rad Laboratories Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 155. Bio-Rad Laboratories Liquid Biopsy Product Offered
Table 156. Bio-Rad Laboratories Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Bio-Rad Laboratories Main Business
Table 158. Bio-Rad Laboratories Latest Developments
Table 1. Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Liquid Biopsy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Test Suite
Table 4. Major Players of Equipment
Table 5. Major Players of Service
Table 6. Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 9. Major Players of NGS Sequencing
Table 10. Major Players of Digital PCR
Table 11. Major Players of Real-time PCR
Table 12. Major Players of Other
Table 13. Liquid Biopsy Market Size CAGR by Technology Platform (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Liquid Biopsy Market Size by Technology Platform (2021-2026) & ($ millions)
Table 15. Global Liquid Biopsy Market Size Market Share by Technology Platform (2021-2026)
Table 16. Major Players of Blood Sample
Table 17. Major Players of Urine Sample
Table 18. Major Players of Other
Table 19. Liquid Biopsy Market Size CAGR by Sample (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Liquid Biopsy Market Size by Sample (2021-2026) & ($ millions)
Table 21. Global Liquid Biopsy Market Size Market Share by Sample (2021-2026)
Table 22. Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 25. Global Liquid Biopsy Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Liquid Biopsy Revenue Market Share by Player (2021-2026)
Table 27. Liquid Biopsy Key Players Head office and Products Offered
Table 28. Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 33. Global Liquid Biopsy Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Liquid Biopsy Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 37. Americas Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 39. Americas Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 41. APAC Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 43. APAC Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 47. Europe Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Liquid Biopsy
Table 53. Key Market Challenges & Risks of Liquid Biopsy
Table 54. Key Industry Trends of Liquid Biopsy
Table 55. Global Liquid Biopsy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Liquid Biopsy Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Liquid Biopsy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Liquid Biopsy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. RainDanceTechnologies Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 60. RainDanceTechnologies Liquid Biopsy Product Offered
Table 61. RainDanceTechnologies Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. RainDanceTechnologies Main Business
Table 63. RainDanceTechnologies Latest Developments
Table 64. Biocartis Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 65. Biocartis Liquid Biopsy Product Offered
Table 66. Biocartis Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Biocartis Main Business
Table 68. Biocartis Latest Developments
Table 69. Qiagen Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 70. Qiagen Liquid Biopsy Product Offered
Table 71. Qiagen Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Qiagen Main Business
Table 73. Qiagen Latest Developments
Table 74. Guardant Health Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 75. Guardant Health Liquid Biopsy Product Offered
Table 76. Guardant Health Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Guardant Health Main Business
Table 78. Guardant Health Latest Developments
Table 79. MDxHealth Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 80. MDxHealth Liquid Biopsy Product Offered
Table 81. MDxHealth Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. MDxHealth Main Business
Table 83. MDxHealth Latest Developments
Table 84. Pathway Genomics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 85. Pathway Genomics Liquid Biopsy Product Offered
Table 86. Pathway Genomics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Pathway Genomics Main Business
Table 88. Pathway Genomics Latest Developments
Table 89. Biocept Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 90. Biocept Liquid Biopsy Product Offered
Table 91. Biocept Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Biocept Main Business
Table 93. Biocept Latest Developments
Table 94. NeoGenomics Laboraories Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 95. NeoGenomics Laboraories Liquid Biopsy Product Offered
Table 96. NeoGenomics Laboraories Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. NeoGenomics Laboraories Main Business
Table 98. NeoGenomics Laboraories Latest Developments
Table 99. Sysmex Inostics Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 100. Sysmex Inostics Liquid Biopsy Product Offered
Table 101. Sysmex Inostics Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Sysmex Inostics Main Business
Table 103. Sysmex Inostics Latest Developments
Table 104. Cynvenio Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 105. Cynvenio Liquid Biopsy Product Offered
Table 106. Cynvenio Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Cynvenio Main Business
Table 108. Cynvenio Latest Developments
Table 109. Silicon Biosystems Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 110. Silicon Biosystems Liquid Biopsy Product Offered
Table 111. Silicon Biosystems Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Silicon Biosystems Main Business
Table 113. Silicon Biosystems Latest Developments
Table 114. Adaptive Biotechnologies Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 115. Adaptive Biotechnologies Liquid Biopsy Product Offered
Table 116. Adaptive Biotechnologies Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Adaptive Biotechnologies Main Business
Table 118. Adaptive Biotechnologies Latest Developments
Table 119. 4D Lifetec Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 120. 4D Lifetec Liquid Biopsy Product Offered
Table 121. 4D Lifetec Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. 4D Lifetec Main Business
Table 123. 4D Lifetec Latest Developments
Table 124. Roche Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 125. Roche Liquid Biopsy Product Offered
Table 126. Roche Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Roche Main Business
Table 128. Roche Latest Developments
Table 129. Illumina Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 130. Illumina Liquid Biopsy Product Offered
Table 131. Illumina Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Illumina Main Business
Table 133. Illumina Latest Developments
Table 134. Exact Sciences Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 135. Exact Sciences Liquid Biopsy Product Offered
Table 136. Exact Sciences Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Exact Sciences Main Business
Table 138. Exact Sciences Latest Developments
Table 139. Natera Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 140. Natera Liquid Biopsy Product Offered
Table 141. Natera Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Natera Main Business
Table 143. Natera Latest Developments
Table 144. Foundation Medicine Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 145. Foundation Medicine Liquid Biopsy Product Offered
Table 146. Foundation Medicine Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Foundation Medicine Main Business
Table 148. Foundation Medicine Latest Developments
Table 149. Thermo Fisher Scientific Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 150. Thermo Fisher Scientific Liquid Biopsy Product Offered
Table 151. Thermo Fisher Scientific Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Thermo Fisher Scientific Main Business
Table 153. Thermo Fisher Scientific Latest Developments
Table 154. Bio-Rad Laboratories Details, Company Type, Liquid Biopsy Area Served and Its Competitors
Table 155. Bio-Rad Laboratories Liquid Biopsy Product Offered
Table 156. Bio-Rad Laboratories Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Bio-Rad Laboratories Main Business
Table 158. Bio-Rad Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liquid Biopsy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Liquid Biopsy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Liquid Biopsy Sales Market Share by Country/Region (2025)
Figure 8. Liquid Biopsy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Liquid Biopsy Market Size Market Share by Type in 2025
Figure 10. Global Liquid Biopsy Market Size Market Share by Technology Platform in 2025
Figure 11. Global Liquid Biopsy Market Size Market Share by Sample in 2025
Figure 12. Liquid Biopsy in Hospitals Labs
Figure 13. Global Liquid Biopsy Market: Hospitals Labs (2021-2026) & ($ millions)
Figure 14. Liquid Biopsy in Reference Labs
Figure 15. Global Liquid Biopsy Market: Reference Labs (2021-2026) & ($ millions)
Figure 16. Liquid Biopsy in Other
Figure 17. Global Liquid Biopsy Market: Other (2021-2026) & ($ millions)
Figure 18. Global Liquid Biopsy Market Size Market Share by Application in 2025
Figure 19. Global Liquid Biopsy Revenue Market Share by Player in 2025
Figure 20. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 22. APAC Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 23. Europe Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 25. Americas Liquid Biopsy Value Market Share by Country in 2025
Figure 26. United States Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Liquid Biopsy Market Size Market Share by Region in 2025
Figure 31. APAC Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 33. China Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Liquid Biopsy Market Size Market Share by Country in 2025
Figure 40. Europe Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 56. APAC Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 57. Europe Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 59. United States Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 60. Canada Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 63. China Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 64. Japan Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 65. Korea Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 67. India Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 68. Australia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 69. Germany Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 70. France Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 71. UK Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 72. Italy Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 73. Russia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 76. Israel Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 78. Global Liquid Biopsy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Liquid Biopsy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 1. Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liquid Biopsy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Liquid Biopsy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Liquid Biopsy Sales Market Share by Country/Region (2025)
Figure 8. Liquid Biopsy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Liquid Biopsy Market Size Market Share by Type in 2025
Figure 10. Global Liquid Biopsy Market Size Market Share by Technology Platform in 2025
Figure 11. Global Liquid Biopsy Market Size Market Share by Sample in 2025
Figure 12. Liquid Biopsy in Hospitals Labs
Figure 13. Global Liquid Biopsy Market: Hospitals Labs (2021-2026) & ($ millions)
Figure 14. Liquid Biopsy in Reference Labs
Figure 15. Global Liquid Biopsy Market: Reference Labs (2021-2026) & ($ millions)
Figure 16. Liquid Biopsy in Other
Figure 17. Global Liquid Biopsy Market: Other (2021-2026) & ($ millions)
Figure 18. Global Liquid Biopsy Market Size Market Share by Application in 2025
Figure 19. Global Liquid Biopsy Revenue Market Share by Player in 2025
Figure 20. Global Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 22. APAC Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 23. Europe Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 25. Americas Liquid Biopsy Value Market Share by Country in 2025
Figure 26. United States Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Liquid Biopsy Market Size Market Share by Region in 2025
Figure 31. APAC Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 33. China Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Liquid Biopsy Market Size Market Share by Country in 2025
Figure 40. Europe Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 56. APAC Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 57. Europe Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 59. United States Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 60. Canada Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 63. China Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 64. Japan Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 65. Korea Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 67. India Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 68. Australia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 69. Germany Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 70. France Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 71. UK Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 72. Italy Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 73. Russia Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 76. Israel Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 78. Global Liquid Biopsy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Liquid Biopsy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Liquid Biopsy Market Size 2027-2032 ($ millions)
